Dolutegravir (GSK1349572)

TypeName: Business Offer
Category:
Offer Date:2018/09/29
Country: United States
Summary: Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
https://www.bocsci.com/dolutegravir-gsk1349572-cas-1051375-16-6-item-438457.html
Description: [RequestDescription]
OfferId: 2140
Name:Alex Brown
Telphone:
Categories